Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Midday movers: Morgan Stanley, Pinterest, Masimo and more

Published 07/18/2023, 08:09 AM
Updated 07/18/2023, 12:46 PM
© Reuters.
BAC
-
PFE
-
MS
-
CMG
-
MASI
-
NVS
-
SHOP
-
PINS
-

Investing.com -- U.S. stocks are rising on Tuesday as investors digested a deluge of corporate earnings, especially from big banks. 

Here are some of the biggest U.S. stock movers today:

  • Bank of America (NYSE:BAC) stock rose 4.7% after the lending giant reported a rise in second-quarter profit as it earned more from customers' loan payments, while its trading arm fared better than expected.

  • Morgan Stanley (NYSE:MS) stock rose 6.7% after the investment bank beat expectations for adjusted profit and revenue as strength in wealth management helped overcome weakness in deal activity.
  • Shopify (NYSE:SHOP) stock fell 2.4% after Evercore ISI downgraded its stance on the e-commerce company to ‘in line’ from ‘outperform,’ saying the risk-reward outlook on the stock is now less compelling.

  • Pinterest (NYSE:PINS) stock rose 3.8% after Evercore ISI upgraded its stance on the image-sharing company to ‘outperform‘ from ‘in line’, citing evidence of stabilizing digital ad spend and potential for recovery.

  • Pfizer (NYSE:PFE) stock rose 1.1% after the drugmaker and venture capital firm Flagship Pioneering agreed to invest $100 million to discover and develop 10 new potential drugs.

  • Chipotle (NYSE:CMG) stock rose 0.6% after the fast food chain signed a deal with Kuwait-based Alshaya Group, its first-ever franchise partner, to open locations in the Middle East next year.

  • Novartis (NYSE:NVS) ADRs rose 4.3% after the Swiss drugmaker raised its full-year profit and revenue outlook following solid second-quarter sales, and proposed a timeline for the spin-off of its Sandoz generic medicines unit.

  • Masimo (NASDAQ:MASI) stock fell 21% after the medical device maker reported weaker-than-expected second-quarter sales due to a weak performance at its healthcare segment.

-- Peter Nurse contributed to this report

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.